Madrigal Pharmaceuticals appointed gastroenterologist Richard S. Levy, MD, to its board of directors, effective immediately.
Here are four points:
1. Additionally, Dr. Levy currently serves on the board of Gliknik, a privately held biopharmaceutical company.
2. Dr. Levy most recently served as executive vice president and chief drug development officer of Incyte.
3. He has also served as an assistant professor of medicine at the University of California Los Angeles School of Medicine.
4. Madrigal is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for the treatment of cardiovascular, metabolic and liver diseases.